Effects of intermittent theta-burst transcranial magnetic stimulation on cognition and hippocampal volumes in bipolar depression.


Journal

Dialogues in clinical neuroscience
ISSN: 1958-5969
Titre abrégé: Dialogues Clin Neurosci
Pays: England
ID NLM: 101238198

Informations de publication

Date de publication:
12 2023
Historique:
entrez: 16 3 2023
pubmed: 17 3 2023
medline: 21 3 2023
Statut: ppublish

Résumé

Repetitive transcranial magnetic stimulation (TMS) is increasingly used to treat neurocognitive symptoms in mood disorders. Intermittent theta burst stimulation (iTBS) is a brief version of TMS that may preferentially target cognitive functions. This study evaluated whether iTBS leads to cognitive improvements and associated increased hippocampal volumes in bipolar depression. In a two-site double-blind randomised sham controlled trial (NCT02749006), 16 patients received active iTBS to the Left Dorsolateral Prefrontal Cortex (DLPF) and 15 patients received sham stimulation across four weeks. A composite neuropsychological score and declarative memory scores served as the cognitive outcomes. Hippocampal volumes were derived from T1 weighted MRI scans using the longitudinal ComBat method to harmonise data across sites. No significant improvements were observed in any cognitive variables in the active relative to the sham group; however, there was a trend for increased left hippocampal volume in the former. Left hippocampal volume increases were associated with improvements in nonverbal memory in the active group. Although cognitive improvements were not associated with iTBS, the finding that hippocampal volume increases were associated with memory improvement suggests there may be some level of prefrontal-temporal neuroplasticity that could support cognitive change in future studies of iTBS in bipolar disorder.

Identifiants

pubmed: 36924413
doi: 10.1080/19585969.2023.2186189
pmc: PMC10026761
doi:

Banques de données

ClinicalTrials.gov
['NCT02749006']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-32

Références

J Cogn Neurosci. 2018 Oct;30(10):1452-1472
pubmed: 29916791
J Affect Disord. 2021 Feb 1;280(Pt A):148-155
pubmed: 33212406
Sci Rep. 2016 Jul 27;6:30537
pubmed: 27460201
Neuron. 2005 Jan 20;45(2):201-6
pubmed: 15664172
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Front Integr Neurosci. 2020 Aug 04;14:35
pubmed: 32848648
Acta Psychiatr Scand Suppl. 2007;(434):17-26
pubmed: 17688459
Lancet. 2018 Apr 28;391(10131):1683-1692
pubmed: 29726344
Brain Stimul. 2020 Sep - Oct;13(5):1211-1217
pubmed: 32512184
Front Neurol. 2020 Dec 21;11:584374
pubmed: 33408684
Science. 2014 Aug 29;345(6200):1054-7
pubmed: 25170153
Lancet Psychiatry. 2017 Mar;4(3):208-217
pubmed: 28185899
Acta Psychiatr Scand. 2013 Sep;128(3):149-62
pubmed: 23617548
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Parkinsonism Relat Disord. 2019 Sep;66:3-8
pubmed: 31300260
J Affect Disord. 2019 Mar 1;246:851-856
pubmed: 30795490
Bipolar Disord. 2018 Mar;20(2):97-170
pubmed: 29536616
Bipolar Disord. 2012 May;14(3):217-26
pubmed: 22548895
Front Neurol. 2020 Nov 05;11:599918
pubmed: 33224103
JAMA Netw Open. 2021 Mar 1;4(3):e210963
pubmed: 33710288
Neuroimage. 2020 Oct 15;220:117129
pubmed: 32640273
Clin Neurophysiol. 2021 Oct;132(10):2568-2607
pubmed: 34482205
J Affect Disord. 2021 Oct 1;293:73-77
pubmed: 34174474
Psychiatry Clin Neurosci. 2017 Nov;71(11):747-758
pubmed: 28631869
Int J Psychophysiol. 2018 Nov;133:169-174
pubmed: 30318052
Braz J Med Biol Res. 2020;53(9):e9481
pubmed: 32725079
Bipolar Disord. 2017 Dec;19(8):614-626
pubmed: 28895274
Neuroimage. 2012 Jul 16;61(4):1402-18
pubmed: 22430496
Depress Anxiety. 2017 Nov;34(11):1029-1039
pubmed: 28543994
Bipolar Disord. 2014 May;16(3):217-29
pubmed: 24219657
Front Neurol. 2021 Jun 30;12:721906
pubmed: 34276553
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Apr 3;66:35-40
pubmed: 26593273
Clin Neurophysiol. 2015 Jun;126(6):1071-1107
pubmed: 25797650
J Psychiatry Neurosci. 2020 Mar 11;45(4):262-270
pubmed: 32159313
Am J Psychiatry. 2008 Feb;165(2):203-13
pubmed: 18172019
eNeuro. 2021 Feb 1;8(1):
pubmed: 33452108
Front Psychiatry. 2019 Mar 29;10:135
pubmed: 30984036
Neuromodulation. 2022 Jun;25(4):596-605
pubmed: 35088728
Neuropsychologia. 2018 Mar;111:344-359
pubmed: 29438672
Bipolar Disord. 2010 Jun;12(4):351-63
pubmed: 20636632
J Affect Disord. 2018 Aug 1;235:20-26
pubmed: 29631203
Hum Brain Mapp. 2022 Jan;43(1):385-398
pubmed: 33073925
Brain Stimul. 2013 May;6(3):346-54
pubmed: 22784443
Eur Neuropsychopharmacol. 2019 Mar;29(3):319-329
pubmed: 30654916
Brain Stimul. 2009 Jan;2(1):50-4
pubmed: 20539835
Psychol Med. 2020 Nov;50(15):2465-2486
pubmed: 33070785
Clin Psychol Rev. 2021 Jun;86:102007
pubmed: 33864968
Exp Neurobiol. 2019 Feb;28(1):1-16
pubmed: 30853820
Neuroimage. 2016 Nov 1;141:542-555
pubmed: 27426838

Auteurs

Ivan J Torres (IJ)

Mood Disorders Centre of Excellence, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.
British Columbia Mental Health and Substance Use Services, Vancouver, British Columbia, Canada.

Ruiyang Ge (R)

Mood Disorders Centre of Excellence, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Alexander McGirr (A)

Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada.
Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.

Fidel Vila-Rodriguez (F)

Non-Invasive Neurostimulation Therapies Laboratory, University of British Columbia, Vancouver, British Columbia, Canada.

Sharon Ahn (S)

Mood Disorders Centre of Excellence, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Jayasree Basivireddy (J)

Mood Disorders Centre of Excellence, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Nazlin Walji (N)

Mood Disorders Centre of Excellence, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Sophia Frangou (S)

Mood Disorders Centre of Excellence, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Raymond W Lam (RW)

Mood Disorders Centre of Excellence, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Lakshmi N Yatham (LN)

Mood Disorders Centre of Excellence, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH